AU9495098A - Methods for use of interleukin 4 (il-4) to treat human immunodeficiency virus infection - Google Patents

Methods for use of interleukin 4 (il-4) to treat human immunodeficiency virus infection

Info

Publication number
AU9495098A
AU9495098A AU94950/98A AU9495098A AU9495098A AU 9495098 A AU9495098 A AU 9495098A AU 94950/98 A AU94950/98 A AU 94950/98A AU 9495098 A AU9495098 A AU 9495098A AU 9495098 A AU9495098 A AU 9495098A
Authority
AU
Australia
Prior art keywords
interleukin
methods
immunodeficiency virus
virus infection
human immunodeficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU94950/98A
Inventor
George N Pavlakis
Antonio L. Valentin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU9495098A publication Critical patent/AU9495098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU94950/98A 1997-09-19 1998-09-18 Methods for use of interleukin 4 (il-4) to treat human immunodeficiency virus infection Abandoned AU9495098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5935997P 1997-09-19 1997-09-19
US60059359 1997-09-19
PCT/US1998/019616 WO1999014378A2 (en) 1997-09-19 1998-09-18 Methods using interleukin 4 to treat hiv infection

Publications (1)

Publication Number Publication Date
AU9495098A true AU9495098A (en) 1999-04-05

Family

ID=22022460

Family Applications (1)

Application Number Title Priority Date Filing Date
AU94950/98A Abandoned AU9495098A (en) 1997-09-19 1998-09-18 Methods for use of interleukin 4 (il-4) to treat human immunodeficiency virus infection

Country Status (2)

Country Link
AU (1) AU9495098A (en)
WO (1) WO1999014378A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
WO2002027321A2 (en) 2000-09-26 2002-04-04 Health Research Incorporated Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients
US7344830B2 (en) 2000-09-26 2008-03-18 Health Research Inc. Heteroduplex tracking assay
US7718356B2 (en) 2000-09-26 2010-05-18 Health Research Inc. Heteroduplex tracking assay

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1834197A (en) * 1996-01-30 1997-08-22 National Institutes Of Health, The Cells expressing both human cd4 and cxcr4
AU3375697A (en) * 1996-05-28 1998-01-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cc chemokine receptor 5, antibodies thereto, transgenic animals
AU3960797A (en) * 1996-06-28 1998-01-21 Dana-Farber Cancer Institute Method for inhibiting hiv-1 infection, drug screens, and methods of diagnosis and prognosis of susceptibility to hiv infection

Also Published As

Publication number Publication date
WO1999014378A3 (en) 1999-10-21
WO1999014378A2 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
HUP9902055A3 (en) Medical composition for the treatment of herpes simplex virus and other infectious diseases
AU3466697A (en) Biological treatment of spent caustics
AU6518890A (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
AU8910891A (en) Treatment of lung diseases
AU4028895A (en) Vaccine and treatment method of Human Immunodeficiency Virus
AU589868B2 (en) Viral inactivation and purification of active proteins
AU2749395A (en) Medical use of bromelain
AU5157998A (en) Methods and compositions for treatment of hepatitis c infection
IL134911A0 (en) Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
AU2886292A (en) Compositions and methods for treatment of epstein-barr virus-associated diseases
AU4088697A (en) Postinfection human immunodeficiency virus (hiv) vaccination therapy
AU2467395A (en) Novel ophthalmologic uses of protein c
AU5758594A (en) Treatment of viral infections
AU9495098A (en) Methods for use of interleukin 4 (il-4) to treat human immunodeficiency virus infection
AU6660090A (en) Treatment of depression
AU7212694A (en) Inhibition of human immunodeficiency virus reproduction by deoxyribonuclease i
AU4602897A (en) Method for treatment of immunodeficiency virus infection
AU5836390A (en) Human lymphoma-associated virus
AU3530395A (en) Treatment of viral infections
AU5425098A (en) Compounds and methods to treat infectious diseases
AU4604697A (en) Compositions and methods for the treatment of human cytomegalovirus infection
AU4319393A (en) Use of indolocarbazols in aids treatment
AU3593095A (en) Method of treatment of human immunodeficiency virus (hiv) infection
AU3742295A (en) Purine and 8-azapurine derivatives suitable to the therapeutic treatment of aids
AU6863191A (en) Treatment of protozoal diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase